Evidence map›Paper›PMID 26660344›Full record

SynthesisSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2016

Interventional options for the management of refractory cancer pain--what is the evidence?

Petra Vayne-Bossert, Banafsheh Afsharimani, Phillip Good, Paul Gray, Janet Hardy

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Multidimensional Treatment of Cancer Pain.Current oncology reports · 2017
    Pooled it
  4. Article
  5. Review
  6. Review
  7. The use of interventional procedures for cancer pain. A brief review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Review
  8. Article
  9. Minimally invasive interventional therapy for pain.Journal of interventional medicine · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. The Role of Ablation in Cancer Pain Relief.Current oncology reports · 2019
    Review
  17. Metastatic Osseous Pain Control: Bone Ablation and Cementoplasty.Seminars in interventional radiology · 2017
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Petra Vayne-BossertReadaptation and Palliative Care, University Hospital of Geneva, Geneva, Switzerland.
Banafsheh AfsharimaniPalliative and Supportive Care, Mater Health Services Brisbane, Raymond Terrace, South Brisbane, 4101, QLD, Australia.
Phillip GoodPalliative and Supportive Care, Mater Health Services Brisbane, Raymond Terrace, South Brisbane, 4101, QLD, Australia.
Paul GraySchool of Medicine, University of Queensland, St Lucia, Australia.
Janet HardyPalliative and Supportive Care, Mater Health Services Brisbane, Raymond Terrace, South Brisbane, 4101, QLD, Australia. janet.hardy@mater.org.au.
Mater Health Services · AUThe University of Queensland · AUUniversity Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePain is the most common symptom in cancer patients. Standard pain treatment according to the WHO three-step analgesic ladder provides effective pain management in approximately 70-90% of cancer patients. Refractory pain is defined as not responding to "standard" treatments. Interventional analgesic techniques can be used in an attempt to control refractory pain in patients in whom conventional analgesic strategies fail to provide effective pain relief or are intolerable due to severe adverse effects. This systematic review aims to provide the latest evidence on interventional refractory pain management in cancer patients.

methodsSystematic literature search in Cochrane, EMBASE and PubMed including reviews and randomised controlled trials (RCTs) and non-randomised controlled trials in the absence of reviews.

resultsNeuraxial analgesia may play a role in refractory cancer pain management. Paravertebral blocks decrease the incidence of persistent post-surgical pain after breast cancer. Coeliac plexus blocks improve pain scores in refractory pancreatic cancer pain for up to 4 weeks after the intervention with fewer burdensome side effects as compared to opioids. Cordotomy has mainly been studied in mesothelioma, and the case series suggest possible benefit for pain at the expense of a relatively high risk of side effects.

conclusionsOverall, very few RCTs have been conducted on interventional pain techniques. In reality, it is very difficult to undertake large controlled trials for a number of reasons. Therefore, today's best evidence for practice may be from large case series of comparable patients with careful response and toxicity evaluation and follow-up.

Indexed as

AnalgesicsAnalgesics, OpioidHumansIntractable PainNeoplasmsPain ManagementAnalgesicsAnalgesics, OpioidCancerInterventional techniquesPain management proceduresRefractory pain

Identifiers

PMID26660344
OpenAlexW2286198456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.